95 related articles for article (PubMed ID: 10530769)
1. Interindividual variability in the expression and NNK carbonyl reductase activity of 11beta-hydroxysteroid dehydrogenase 1 in human lung.
Soldan M; Nagel G; Losekam M; Ernst M; Maser E
Cancer Lett; 1999 Oct; 145(1-2):49-56. PubMed ID: 10530769
[TBL] [Abstract][Full Text] [Related]
2. 11Beta-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes.
Maser E
Cancer Res; 1998 Jul; 58(14):2996-3003. PubMed ID: 9679962
[TBL] [Abstract][Full Text] [Related]
3. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung.
Finckh C; Atalla A; Nagel G; Stinner B; Maser E
Chem Biol Interact; 2001 Jan; 130-132(1-3):761-73. PubMed ID: 11306092
[TBL] [Abstract][Full Text] [Related]
4. Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung.
Atalla A; Maser E
Toxicology; 1999 Nov; 139(1-2):155-66. PubMed ID: 10614696
[TBL] [Abstract][Full Text] [Related]
5. Purification, characterization and NNK carbonyl reductase activities of 11beta-hydroxysteroid dehydrogenase type 1 from human liver: enzyme cooperativity and significance in the detoxification of a tobacco-derived carcinogen.
Maser E; Friebertshäuser J; Völker B
Chem Biol Interact; 2003 Feb; 143-144():435-48. PubMed ID: 12604230
[TBL] [Abstract][Full Text] [Related]
6. Characterization of enzymes participating in carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human placenta.
Atalla A; Maser E
Chem Biol Interact; 2001 Jan; 130-132(1-3):737-48. PubMed ID: 11306090
[TBL] [Abstract][Full Text] [Related]
7. Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytosolic enzymes in human liver and lung.
Maser E; Stinner B; Atalla A
Cancer Lett; 2000 Feb; 148(2):135-44. PubMed ID: 10695989
[TBL] [Abstract][Full Text] [Related]
8. Enantioselectivity of carbonyl reduction of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by tissue fractions from human and rat and by enzymes isolated from human liver.
Breyer-Pfaff U; Martin HJ; Ernst M; Maser E
Drug Metab Dispos; 2004 Sep; 32(9):915-22. PubMed ID: 15319331
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol.
Atalla A; Breyer-Pfaff U; Maser E
Xenobiotica; 2000 Aug; 30(8):755-69. PubMed ID: 11037109
[TBL] [Abstract][Full Text] [Related]
10. The identification of 11 beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Maser E; Richter E; Friebertshäuser J
Eur J Biochem; 1996 Jun; 238(2):484-9. PubMed ID: 8681962
[TBL] [Abstract][Full Text] [Related]
11. Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via alpha-hydroxylation and carbonyl reduction pathways.
Prokopczyk B; Trushin N; Leszczynska J; Waggoner SE; El-Bayoumy K
Carcinogenesis; 2001 Jan; 22(1):107-14. PubMed ID: 11159748
[TBL] [Abstract][Full Text] [Related]
12. Human 11beta-hydroxysteroid dehydrogenase 1/carbonyl reductase: recombinant expression in the yeast Pichia pastoris and Escherichia coli.
Blum A; Martin HJ; Maser E
Toxicology; 2000 Apr; 144(1-3):113-20. PubMed ID: 10781878
[TBL] [Abstract][Full Text] [Related]
13. 11Beta-hydroxysteroid dehydrogenase 1 expression in squamous cell carcinomas of the head and neck.
Gronau S; Koenig Greger D; Jerg M; Riechelmann H
Clin Otolaryngol Allied Sci; 2002 Dec; 27(6):453-7. PubMed ID: 12472511
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells.
Smith GB; Castonguay A; Donnelly PJ; Reid KR; Petsikas D; Massey TE
Carcinogenesis; 1999 Sep; 20(9):1809-18. PubMed ID: 10469628
[TBL] [Abstract][Full Text] [Related]
15. Stereochemical aspects of carbonyl reduction of the original anticancer drug oracin by mouse liver microsomes and purified 11beta-hydroxysteroid dehydrogenase type 1.
Wsól V; Szotáková B; Skálová L; Maser E
Chem Biol Interact; 2003 Feb; 143-144():459-68. PubMed ID: 12604232
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of 11beta-hydroxysteroid dehydrogenase type 1/microsomal carbonyl reductase (11beta-HSD/CR) in guinea pig tissues. Purification of the liver form suggests modification in the cosubstrate binding site.
Oppermann UC; Möbus E; Nagel G; Maser E
Toxicology; 2000 Apr; 144(1-3):63-9. PubMed ID: 10781872
[TBL] [Abstract][Full Text] [Related]
17. Sex hormones reduce NNK detoxification through inhibition of short-chain dehydrogenases/reductases and aldo-keto reductases in vitro.
Stapelfeld C; Maser E
Chem Biol Interact; 2017 Oct; 276():167-173. PubMed ID: 28257955
[TBL] [Abstract][Full Text] [Related]
18. Absence of type 1 11beta-hydroxysteroid dehydrogenase enzyme in koala liver.
Kong S; McKinnon RA; Mojarrabi B; Stupans I
Comp Biochem Physiol C Toxicol Pharmacol; 2002 Jan; 131(1):39-50. PubMed ID: 11796324
[TBL] [Abstract][Full Text] [Related]
19. Role of type-1 11beta-hydroxysteroid dehydrogenase in detoxification processes.
Maser E; Oppermann UC
Eur J Biochem; 1997 Oct; 249(2):365-9. PubMed ID: 9370342
[TBL] [Abstract][Full Text] [Related]
20. Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes.
Smith TJ; Liao AM; Liu Y; Jones AB; Anderson LM; Yang CS
Carcinogenesis; 1997 Aug; 18(8):1577-84. PubMed ID: 9276633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]